Association between the PTPN2 gene and Crohn's Disease: Dissection of potential causal variants

Inflammatory Bowel Diseases

Volumn 19, Issue 6, 2013, Pages 1149-1155

  Marcil, Valerie ^a   Mack, David R ^b   Kumar, Vijay ^c   Faure, Christophe ^a,d   Carlson, Christopher S ^e   Beaulieu, Patrick ^a   Israel, David ^f   Krupoves, Alfreda ^a,d   Costea, Irina ^g   Lambrette, Philippe ^a   Grimard, Guy ^a,d   Dong, Jinsong ^a   Seidman, Ernest G ^a   Amre, Devendra K ^a,d   Levy, Emile ^a,h  

^a MCGILL UNIVERSITY   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITY OF WASHINGTON   (United States)

^f BC CHILDREN S HOSPITAL   (Canada)

^g PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^h UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Association; Children; Crohn's disease; Protein; PTPN2 gene

Indexed keywords

NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; CROHN DISEASE; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE OVEREXPRESSION; GENE SEQUENCE; GENE TARGETING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTRON; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMPUTATIONAL BIOLOGY; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOBLOTTING; INFANT; INFANT, NEWBORN; INFLAMMATION; INTESTINAL MUCOSA; LINKAGE DISEQUILIBRIUM; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; RISK FACTORS;

EID: 84879194656     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e318280b181     Document Type: Article

References (39)

1. Welcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-678.
2. Imielinski M, Baldassano RN, Griffiths A, et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet. 2009;41:1335-1340.
3. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008;40:955-962.
4. Franke A, McGovern DP, Barrett JC, et al Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42:1118-1126.
5. Ibarra-Sánchez MJ, Simoncic PD, Nestel FR, et al. The T-cell protein tyrosine phosphastase. Sem Immunol. 2000;12:379-386.
6. + myeloid cells lacking T cell protein tyrosine phosphatase inhibit lymphocyte proliferation by an IFN-γ- and nitric oxide-dependent mechanism. J Immunol. 2003;171:726-732.
7. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autoph-agy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007;39:830-832.
8. Franke A, Balschun T, Karlsen TH, et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet. 2008;40:713-715.
9. Kugathasan S, Baldassano RN, Bradfield JP, et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet. 2008;40:1211-1215.
10. Essers JB, Lee JJ, Kugathasan S, et al. Established genetic risk factors do not distinguish early and later onset Crohn's disease. Inflamm Bowel Dis. 2009;15:1508-1514.
11. Amre DK, Mack DR, Morgan K, et al. Association between genome-wide association studies reported SNPs and pediatric-onset Crohn's disease in Canadian children. Hum Genet. 2010;128:131-135.
12. Amre DK, Mack DR, Morgan K, et al. Susceptibility loci reported in genome-wide association studies are associated with Crohn's disease in children. Aliment Pharmacol Ther. 2010;31: 1186-1191.
13. Amre DK, Mack DR, Morgan K, et al. Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children. Inflamm Bowel Dis. 2009;15: 501-507.
14. Amre DK, Mack DR, Morgan K, et al. Investigation of reported associations between the 20q13 and 21q22 loci and pediatric-onset Crohn's disease in Canadian children. Am J Gastroenterol. 2009;104: 2824-2828.
15. Amre DK, Mack DR, Morgan K, et al. Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease. Aliment Pharmacol Ther. 2009;29: 1025-1031.
16. Amre DK, Mack D, Israel D, et al. Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children. Am J Gastroenterol. 2008;103: 615-620.
17. Carlson CS, Eberle MA, Rieder MJ, et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2004;74:106-120.
18. Dixon AL, Liang L, Moffatt MF, et al. A genome-wide association study of global gene expression. Nat Genet. 2007;39:1202-1207.
19. Ernst J, Plasterer HL, Simon I, et al. Integrating multiple evidence sources to predict transcription factor binding in the human genome. Genome Res. 2010;20:526-536.
20. Ge B, Pokholok DK, Kwan T, et al. Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat Genet. 2009;41:1216-1222.
21. Levy E, Trudel K, Bendayan M, et al. Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats. Am J Physiol Gastrointest Liver Physiol. 2007;293:G1252-G1261.
22. Sané AT, Sinnett D, Delvin E, et al. Localization and role of NPC1L1 in cholesterol absorption in human intestine. J Lipid Res. 2006;47: 2112-2120.
23. Giacopelli F, Rosatto N, Divizia MT, et al. The first intron of the human osteopontin gene contains a C/EBP-beta-responsive enhancer. Gene Expr. 2003;11:95-104.
24. Hugo H, Cures A, Suraweera N, et al. Mutations in the MYB intron I regulatory sequence increase transcription in colon cancers. Genes Chromosomes Cancer. 2006;45: 1143-1154.
25. Baralle M, Pastor T, Bussani E, et al. Influence of Friedreich ataxia GAA noncoding repeat expansions on pre-mRNA processing. Am J Hum Genet. 2008;83:77-88.
26. Buratti E, Brindisi A, Pagani F, et al. Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am J Hum Genet. 2004; 74:1322-1325.
27. *TTC triplet repeat expanded in Friedreich's ataxia impedes transcription elongation by T7 RNA polymerase in a length and supercoil dependent manner. Nucleic Acids Res. 2000;28: 2815-2822.
28. Marcil V, Seidman EG, Sinnett D, et al. Modification in oxidative stress, inflammation and lipoprotein assembly in response to hepatocyte nuclear factor 4 alpha knockdown in intestinal epithelial cells. J Biol Chem. 2010; 285:40448-40460.
29. The UK IBD Genetics Consortium and the Welcome Trust Case Control Consortium 2. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci including the HNF4A region. Nat Genet. 2009;41:1330-1334.
30. Martin H. Role of PPAR-gamma in inflammation Prospects for therapeutic intervention by food components. Mutat Res. 2010;690:57-63.
31. Hebenstreit D, Wirnsberger G, Horejs-Hoeck J, et al. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev. 2006;17:173-188.
32. Momozawa Y, Mni M, Nakamura K, et al. Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease Nat Genet. 2011;43:43-47.
33. Rivas MA, Beaudoin M, Gardet A, et al. Deep resequencing of GWAS loci identified independent rare variants associated with inflammatory bowel disease. Nat Genet. 2011;43:1066-1075.
34. Dickson SP, Wang K, Krantz I, et al. Rare variants create synthetic genome-wide associations. PLoS Biol. 2010;8:e1000294.
35. Doody KM, Bourdeau A, Tremblay ML. T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease. Immunol Rev. 2009;228: 325-341.
36. Scharl M, Paul G, Weber A, et al. Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2. Gastroenterology. 2009;137:2030-2040.
37. Scharl M, McCole DF, Weber A, et al. Protein tyrosine phosphatase N2 regulates TNF-alpha induced signaling and cytokine secretion in human intestinal epithelial cells. Gut. 2011;60:189-197.
38. Scharl M, Mwinyi J, Fischbeck A, et al. Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy. Inflamm Bowel Dis. 2011;18:900-912.
39. Scharl M, Wojtal KA, Becker HM, et al. Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells. Inflamm Bowel Dis. 2012;18:1287-1302.